Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

Astellas files diabetes drug ipragliflozin in Japan

Its SGLT2 inhibitor could beat AZ-BMS' rival Forxiga to debut in that market

- PMLiVE

Merck taps Luminex for Alzheimer’s biomarker

Licenses companion diagnostic to use in its clinical trials

- PMLiVE

GSK’s Ellen Strahlman joins med tech firm BD

Will serve as the US company's chief medical officer

- PMLiVE

The future of market access through a communications lens

Communications will play a pivotal role in helping pharma to define the value agenda

- PMLiVE

Dr Theo de Roij joins RSA

He will be based in the recruitment firm's Belgium office

Doctors move dementia assessment from paper to smartphone

Evidence-based ACEmobile app soon to be launched

- PMLiVE

Johnson & Johnson opens London innovation centre

Centre will serve as European hub for its healthcare innovation efforts

- PMLiVE

ACC and Boehringer develop CME programme in China

Will focus on stroke prevention in atrial fibrillation

Aeterna Zentaris under the cosh as myeloma candidate fails

Phase III trial of perifosine halted after poor results

Shire acquires Swiss biotech Premacure

Gains phase II eye drug for rare infant condition

- PMLiVE

Merck forges on with Vytorin trial after safety review

Won't halt controversial study of its cholesterol drug

- PMLiVE

Letting the patient voice be heard

How well is your campaign really reflecting patient insights – or is it more about what you or their HCPs want them to hear?

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links